Published in Br J Clin Pharmacol on June 01, 1990
Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda. Antimicrob Agents Chemother (2009) 1.52
Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers. Eur J Clin Pharmacol (2008) 1.39
Population pharmacokinetics of artesunate and amodiaquine in African children. Malar J (2009) 1.26
The disposition of oral amodiaquine in Papua New Guinean children with falciparum malaria. Br J Clin Pharmacol (2005) 1.25
Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers. Eur J Clin Pharmacol (2009) 1.23
Determinants of the cost-effectiveness of intermittent preventive treatment for malaria in infants and children. PLoS One (2011) 1.12
Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria. Antimicrob Agents Chemother (2008) 1.10
Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy. Antimicrob Agents Chemother (2012) 1.04
Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria. Antimicrob Agents Chemother (2011) 1.01
Population pharmacokinetics and pharmacodynamic considerations of amodiaquine and desethylamodiaquine in Kenyan adults with uncomplicated malaria receiving artesunate-amodiaquine combination therapy. Antimicrob Agents Chemother (2010) 0.93
Synergism between amodiaquine and its major metabolite, desethylamodiaquine, against Plasmodium falciparum in vitro. Antimicrob Agents Chemother (2004) 0.80
Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines. Malar J (2005) 0.78
Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. J Antimicrob Chemother (2014) 0.78
Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combination in areas of malaria endemicity. Antimicrob Agents Chemother (2015) 0.75
Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studies. J Med Chem (2011) 0.75
Clinical pharmacokinetics of antimalarial drugs. Clin Pharmacokinet (1985) 3.03
Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans. Life Sci (1985) 2.21
Amodiaquine induced agranulocytosis and liver damage. Br Med J (Clin Res Ed) (1986) 2.08
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet (1986) 2.04
Fatal agranulocytosis during treatment with a amodiaquine. Br Med J (1957) 1.84
Kinetics of the uptake and elimination of chloroquine in children with malaria. Br J Clin Pharmacol (1982) 1.83
Absolute neutrophil leucopenia after uncontrolled use of amodiaquine. Br Med J (1955) 1.74
Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet (1984) 1.61
Nearly fatal reaction to amodiaquine. JAMA (1962) 1.59
Evaluation of amodiaquin (camoquin) in the treatment of relapsing vivax malaria. Am J Med Sci (1953) 1.56
The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol (1987) 1.49
High-affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium berghei. J Clin Invest (1974) 1.37
A comparison of the in vitro activities of amodiaquine and desethylamodiaquine against isolates of Plasmodium falciparum. Am J Trop Med Hyg (1989) 1.27
Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. Eur J Clin Pharmacol (1987) 1.15
Agranulocytosis coincident with amodiaquine therapy. Br Med J (1967) 1.13
A 15 month controlled study of the effects of amodiaquine (camoquin) in rheumatoid arthritis. Arthritis Rheum (1959) 1.13
The effect of amodiaquin (camoquin) on the course of rheumatoid arthritis. Arthritis Rheum (1959) 1.11
Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine. Br J Clin Pharmacol (1987) 1.10
Simultaneous determination of chloroquine, amodiaquine and their metabolites in human plasma, red blood cells, whole blood and urine by column liquid chromatography. J Chromatogr (1986) 1.09
Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents. Br Med J (Clin Res Ed) (1986) 1.07
Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance. Trans R Soc Trop Med Hyg (1988) 0.94
Sensitive analysis of blood for amodiaquine and three metabolites by high-performance liquid chromatography with electrochemical detection. J Chromatogr (1986) 0.89
Neutropenia and prophylactic amodiaquine. Lancet (1986) 0.87
Amodiaquine fails to cure chloroquine resistant Plasmodium falciparum in the Punjab. Trans R Soc Trop Med Hyg (1987) 0.87
Tissue distribution and excretion of amodiaquine in the rat. J Pharm Pharmacol (1988) 0.83
Amodiaquin accumulation by mouse erythrocytes infected with Plasmodium berghei. J Pharmacol Exp Ther (1975) 0.82
Amodiaquine less effective than chloroquine in the treatment of falciparum malaria in the Philippines. Am J Trop Med Hyg (1987) 0.81
Review of company postmarketing surveillance studies. BMJ (1992) 6.21
The alcohol dependence syndrome: a concept as stimulus to enquiry. Br J Addict (1986) 5.32
London's skid row. Lancet (1966) 5.09
Alcohol dependence: provisional description of a clinical syndrome. Br Med J (1976) 4.96
Cimetidine: interaction with oral anticoagulants in man. Lancet (1979) 4.67
Science and the drinks industry: cause for concern. Addiction (1996) 4.63
Sensible drinking. BMJ (1996) 4.38
Alcoholism: a controlled trial of "treatment" and "advice". J Stud Alcohol (1977) 4.14
ILSI Europe, the drinks industry, and a conflict of interest undeclared. Addiction (2001) 3.76
A controlled trial of inpatient and outpatient treatment of alcohol dependency. Lancet (1967) 3.41
Adverse drug reactions. BMJ (1998) 3.25
Specialist versus general practitioner treatment of problem drinkers. Lancet (1990) 2.88
Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol (1983) 2.59
Abolition of cost-sharing is pro-poor: evidence from Uganda. Health Policy Plan (2005) 2.57
Deaths of drug addicts in the United Kingdom 1967-81. Br Med J (Clin Res Ed) (1985) 2.35
Contemporary themes: relevance of american experience of narcotic addiction to the british scene. Br Med J (1967) 2.29
Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD). J Abnorm Child Psychol (2001) 2.27
The British approach to the treatment of heroin addiction. Lancet (1969) 2.26
Clinical implications of enzyme induction and enzyme inhibition. Clin Pharmacokinet (1981) 2.25
Drugs, drug dependence and the concept of plasticity. Q J Stud Alcohol (1974) 2.17
The pharmacokinetics of combination therapy with nelfinavir plus nevirapine. AIDS (1998) 2.16
The development of a questionnaire to measure severity of alcohol dependence. Br J Addict Alcohol Other Drugs (1979) 2.16
Abuse of methylamphetamine. Br Med J (1969) 2.15
Antidepressants and heart disease. Br Med J (Clin Res Ed) (1984) 2.14
Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine). Clin Sci (1971) 2.11
Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA(LGA251). Clin Microbiol Infect (2012) 2.08
An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol (2004) 2.05
Addiction treatment and the making of large claims. Addiction (2000) 2.05
Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet (1986) 2.04
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol (2001) 2.03
Shakespeare and the meaning of authorship. Addiction (2000) 2.02
An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassay. Contraception (1979) 1.97
Pharmacokinetics of halofantrine in man: effects of food and dose size. Br J Clin Pharmacol (1989) 1.97
Cocaine and crack. BMJ (1989) 1.96
Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol (2002) 1.94
Dose-dependent enzyme induction. Clin Pharmacol Ther (1973) 1.84
Kinetics of the uptake and elimination of chloroquine in children with malaria. Br J Clin Pharmacol (1982) 1.83
Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br J Clin Pharmacol (1984) 1.82
May mothers given warfarin breast-feed their infants? Br Med J (1977) 1.80
Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. Br J Clin Pharmacol (1983) 1.77
Inter-subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man. Br J Clin Pharmacol (1989) 1.71
Investigations to characterize a new anti-arrhythmic drug, ORG 6001 including a simple test for calcium antagonism. Br J Pharmacol (1976) 1.71
Pruritus and antimalarial drugs in Africans. Lancet (1989) 1.70
Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol (2004) 1.67
Relevance and utility of courses in medical ethics. A survey of physicians' perceptions. JAMA (1985) 1.67
Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS (1997) 1.65
Census of a reception centre. Br J Psychiatry (1968) 1.64
Clinical pharmacokinetics of oral contraceptive steroids. Clin Pharmacokinet (1983) 1.64
Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol (1993) 1.64
The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol (1987) 1.63
Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet (1990) 1.63
Improved fluorimetric assay of chloroquine in biological samples. J Pharm Pharmacol (1980) 1.62
Orthodontic auxiliaries--a pilot project. Br Dent J (1998) 1.59
Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics. Br J Clin Pharmacol (1988) 1.56
The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study. Br J Clin Pharmacol (1991) 1.54
Blood pressure, hypertension and correlates in urbanised workers in Ibadan, Nigeria: a revisit. J Hum Hypertens (1999) 1.54
Transcription factor E2F binds DNA as a heterodimer. Proc Natl Acad Sci U S A (1993) 1.53
Characterization of potassium currents modulated by BRL 38227 in rat portal vein. Br J Pharmacol (1992) 1.50
Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro Surveill (2003) 1.50
The disposition of amodiaquine in man after oral administration. Br J Clin Pharmacol (1987) 1.49
The disposition of chloroquine and its main metabolite desethylchloroquine in volunteers with and without chloroquine-induced pruritus: evidence for decreased chloroquine metabolism in volunteers with pruritus. Clin Pharmacol Ther (2000) 1.48
Parenteral sulphadoxine-pyrimethamine (Fansidar): an effective and safe but under-used method of anti-malarial treatment. Trans R Soc Trop Med Hyg (1991) 1.48
Nomenclature and classification of drug- and alcohol-related problems: a WHO Memorandum. Bull World Health Organ (1981) 1.46
Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum. Lancet (1987) 1.46
A study of the effect of anticoagulants on [3H]vitamin K1 metabolism and prothrombin complex activity in the rabbit. Biochem Pharmacol (1979) 1.46
The alcoholic doctor. A case of neglect. Lancet (1975) 1.45
Lack of effect of ranitidine on warfarin action. Br J Clin Pharmacol (1981) 1.45
Trial of combination of guanethidine and oxprenolol in hypertension. Br Med J (1976) 1.44
The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes. Br J Clin Pharmacol (1991) 1.42
Effects of amiloride on active sodium transport by the isolated frog skin: evidence concerning site of action. Br J Pharmacol (1970) 1.42
The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites. AIDS (1996) 1.41
Hypnosis and desinsitization for Phobias: a controlled prospective trial. Br J Psychiatry (1968) 1.40
Abstinence or control: the outcome for excessive drinkers two years after consultation. Behav Res Ther (1976) 1.40
The interaction of antibiotics with synthetic steroids in the rat [proceedings]. Br J Pharmacol (1978) 1.40
Who was Jellinek? Br J Psychiatry (1991) 1.39
Effects of methyl beta-cyclodextrin on EDHF responses in pig and rat arteries; association between SK(Ca) channels and caveolin-rich domains. Br J Pharmacol (2007) 1.39
A paper which must be withdrawn from publication. Addiction (2001) 1.38
Malaria in Nigeria: a revisit. Ann Trop Med Parasitol (1990) 1.38
Interindividual variation and drug interactions with hormonal steroid contraceptives. Drugs (1981) 1.36
Comparative efficacy of halofantrine, chloroquine and sulfadoxine-pyrimethamine for treatment of acute uncomplicated falciparum malaria in Nigerian children. Trans R Soc Trop Med Hyg (1997) 1.36
On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther (1983) 1.34
Interindividual differences in the response to oral anticoagulants. Drugs (1977) 1.34
Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children. Trans R Soc Trop Med Hyg (1997) 1.34
Changes in sodium pool and kinetics of sodium transport in frog skin produced by amiloride. Br J Pharmacol (1970) 1.33
The burden of alcohol misuse on an inner-city general hospital. QJM (2000) 1.31
Determination of primaquine in biological fluids by reversed-phase high-performance liquid chromatography. J Chromatogr (1984) 1.30
Drinking problems: putting the Third World on the map. Lancet (1979) 1.30